🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Loved catching up with my forever mentor Dr. Hanna Mikkola ⁦ASH⁩. She can still get me so fired up about HSC biology!!

Learn about the value & power of molecular profiling in improving outcomes for MDS & AML patients at RRP's #meded webinar Wed, April 26 w/ Dr. Daniel Pollyea & guest panelists Dr. Eytan Stein Memorial Sloan Kettering Cancer Center & Dr. Gabriel Mannis Stanford Health Care Register: ow.ly/kAIf50NolCP

Beautiful work by Siddhartha Jaiswal, Alex Bick and colleagues. Fascinating to learn that specific somatic mutations in HSCs drive expression of TCL1A which in turn promotes clonal expansion.

4 more days !!! To fill out this survey. Data will be presented during SSC session ISTH

We’re taking to the road for this year’s #XOutCancer Campaign w/ the RRP Walk & Roll! Join us for a virtual walk/run to raise funds & awareness for #RUNX1FPD & cancer prevention research. 💪Click the link below to learn more, donate & spread the word! 🏃 ow.ly/FBao50NRtm1

Today’s the day to begin to Walk & Roll with the 2023 X-Out Cancer Challenge! Join us throughout the month of May by walking (or running, or rolling) toward a cure for #RUNX1FPD. 🏃 Support, participate and donate through the link below! #PREVENTCANCER ow.ly/FBao50NRtm1

Germline predispositions to MDS.. not that rare! Way to go Kelly Bolton MD PhD!! Congratulations!

Congratulations to an incredibly talented young scientist! Dr. Amy Fan has made a huge impact on the RUNX1 research field not only b/c of her thesis work but b/c she is a wonderful human being, easy to collaborate with and filled with a passion to make a difference for pts.

RRP & Alex's Lemonade Stand Foundation are thrilled to announce that Dr. Brittany Stewart received a 2023 RRP-ALSF RUNX1 Early Career Investigator-Clinical Research Grant! Learn more about her plans to develop the first guidelines for the diagnosis & treatment of RUNX1-FPD: ow.ly/uugl50Ok3KX

It's our annual RRP X-Out Cancer campaign. Please help me raise money for RUNX1-FPD research. You all know how expensive research is. Your gift means a lot. Plus, I pledged to run 21 days of the month in honor of RUNX1 on chromosome 21. Thank you! ♥️ givebutter.com/xout23/katrine…

We are close to the end of the #XOutCancer campaign. Help us raise awareness and funds for cancer prevention research that has the potential to save lives. Support the campaign now through June 4th! #cancerresearch #bloodcancer ow.ly/FBao50NRtm1

ONE WEEK away from the deadline to submit your research abstracts for potential inclusion in our 7th Annual Scientific Conference poster session! Submission is open to anyone, so please share this opportunity and these guidelines within your network: ow.ly/ftGr50PeyJu

Academics outside the US can now apply to access AllofUsResearch. Please spread the word! allofus.nih.gov/news-events/an… cc: Daniel MacArthur Cecilia Lindgren @timfrayling @minouye271 Nicole Soranzo Guillaume Lettre Samuli Ripatti Shai Carmi J. Gustav Smith Andrea ganna Paul Lacaze James Ware Nicky Whiffin

Register for our next #MedEd webinar, “Pulling the Molecular Thread Through Pediatric Thrombocytopenia, MDS and AML” on Monday, Sept. 11! Experts from Children's Hospital & Stanford University will discuss the importance of accurate diagnoses with these conditions. ow.ly/cRzb50PgFQ4

Great opportunity to submit your RUNX1-FPD preclinical model project proposals! Please submit an LOI.

Results from a recent clinical trial suggest that a new three-drug regimen might reduce the risk of graft-versus-host disease after stem cell transplant, potentially making a significant step toward improving patient outcomes. Learn more from this National Cancer Institute article.

Check out this open grant opportunity established by our friends at Alex's Lemonade Stand Foundation. Here's to accelerating discoveries for effective treatments for all children with cancers.

Check out this Genomenon webinar on Sept 21st focused on the classification of splice variants in hereditary cancer genes with guest speaker Dr. Randi Rawson of Myriad Genetics

This Monday is our #MedEd webinar to discuss the impact of molecular profiling in #MDS & #AML patient outcomes. Dr. Daniel Pollyea of CU Anschutz Division of Hematology presents & joins a Q&A with Dr. Catherine Smith, MD from UC San Francisco & Dr. Amir Fathi from Mass General Cancer Center. Register now: ow.ly/sVZP50Q5Je4

Learn about our group's efforts to apply AI Models to single cell RNA-seq data to find cures for RUNX1-FPD with Anupriya Agarwal Lab @LabObeng Katrin Ericson & RUNX1 Research Program supported by CZI Science in GenomeWeb. Vanderbilt University Medical Center @VUMCgenetics genomeweb.com/informatics/ai…